U.S. Household Products Stock News

Ligand Pharmaceuticals (LGND) has reported FY 2025 results with fourth quarter revenue of US$59.7 million and basic EPS of US$2.27, while trailing twelve month figures show revenue of US$268.1 million and basic EPS of US$6.44. Over the past few quarters, the company has seen revenue move from US$42.8 million in Q4 2024 to US$45.3 million in Q1 2025, US$47.6 million in Q2 2025, US$115.5 million in Q3 2025 and US$59.7 million in Q4 2025, alongside basic EPS ranging from a loss of US$2.21 in Q1...

Recent analysis of Nutex Health’s hybrid model of micro-hospitals, hospital management services, and population health programs highlighted strong profitability metrics and claims of deep undervaluation, drawing fresh investor attention in the past week. An interesting angle is the company’s high free cash flow conversion, which some commentators argue could support a meaningful reassessment of its valuation if operating performance holds. We’ll now examine how Nutex Health’s highlighted...

Centrus Energy has in recent months secured a US$900 million High-Assay Low-Enriched Uranium contract from the U.S. Department of Energy and committed hundreds of millions of dollars to expand its Oak Ridge and Piketon enrichment plants, reinforcing its role in a reshaped Western nuclear fuel supply chain. An important takeaway is that Centrus now sits at the center of a multi‑billion‑dollar backlog through 2040, reflecting how policy shifts away from Russian uranium have turned its unique...

AbCellera Biologics Inc. has reported its full-year 2025 results, with revenue rising to US$75.13 million and net loss easing to US$146.41 million, while also filing a US$45.54 million shelf registration for 15,030,034 common shares tied to an employee share offering. Alongside these financials, AbCellera’s shift into a clinical-stage biotech with advancing programs ABCL635 and ABCL575 and a nearly completed manufacturing facility signals a business model increasingly centered on internal...

International Seaways (INSW) is back in focus after reporting record fourth quarter net income and pairing those results with its largest ever quarterly dividend, a combined US$2.15 per share. See our latest analysis for International Seaways. The latest earnings and dividend news has arrived after a strong run in the shares, with a 30 day share price return of 26.6% and a year to date gain of 60.74%. That move sits on top of a very large 1 year total shareholder return of 143.19% and a 5...

Morgan Stanley and UBS recently upgraded Ermenegildo Zegna Group, following Q4 2025 sales that came in ahead of earlier expectations and highlighted broad-based strength in the core Zegna brand. Analysts pointed to strong engagement from Western affluent consumers across generations as evidence that Zegna’s brand and product positioning are resonating across key demographics. We’ll now examine how this renewed analyst confidence, driven by stronger-than-expected Q4 sales, may influence...

Coursera stock snapshot and recent performance Coursera (COUR) closed at US$6.41, with the share price showing a small gain over the past month but a decline over the past 3 months and past year, including a negative 3 year total return. The company reports annual revenue of US$757.5m and a net loss of US$51.0m. Recent annual figures indicate positive revenue and net income growth, factors some investors watch when assessing an education technology platform. See our latest analysis for...

Arlo Technologies (ARLO) closed out FY 2025 with Q4 revenue of US$141.3 million and basic EPS of US$0.05, alongside net income of US$5.8 million. The trailing 12 month line shows revenue of US$529.3 million and basic EPS of US$0.14 as the business moves further into consistent profitability. Over the past six quarters, the company has seen revenue range from US$119.1 million to US$141.3 million per quarter, with basic EPS shifting from a loss of US$0.05 in late 2024 to positive contributions...

In February 2026, CCC Intelligent Solutions Holdings reported fourth-quarter 2025 revenue of US$277.87 million and net income of US$8.12 million, crossing US$1.06 billion in full‑year sales and issuing 2026 revenue guidance of US$1.15 billion to US$1.16 billion. The results highlighted nearly US$100 million in annual revenue from AI solutions, the EvolutionIQ acquisition to broaden insurance end‑markets, and a new US$500 million share repurchase authorization, including an accelerated US$300...

Helix Energy Solutions Group (HLX) is back in focus after reporting its highest fourth quarter revenue since 2013, positive free cash flow, and year end cash and liquidity that support recently secured multiyear contracts. See our latest analysis for Helix Energy Solutions Group. Those results come after a busy period, with Helix Energy Solutions Group reporting full year 2025 earnings, recording a US$18.06 million long lived asset impairment, completing its share repurchase program, and...

In February 2026, Arcutis Biotherapeutics reported fourth-quarter 2025 revenue of US$129.5 million and full-year revenue of US$376.07 million, moved to a Q4 net profit of US$17.4 million, and raised its 2026 net product revenue guidance to US$480 million–US$495 million while filing an omnibus shelf registration for multiple securities. The results highlight how rapid uptake of ZORYVE across expanded indications, including pediatric use, is beginning to translate into improving profitability...

Corporación América Airports (CAAP) caught investor attention after its January 2026 operating update, with total passenger traffic rising 8.8% year on year. Argentina and Brazil led with record and double digit gains. See our latest analysis for Corporación América Airports. That operating update lands after a mixed few weeks for the share price, with a 1 day share price decline of 1.59% and a 7 day share price decline of 2.56%, but a stronger 90 day share price return of 12.43% and a very...

If you are wondering whether Oddity Tech is now a bargain or a value trap, a closer look at how its current share price lines up with its fundamentals can help frame that question. The stock has seen large price swings recently, with a 7 day return of 63.2% decline, a 30 day return of 64.8% decline, and a year to date return of 70.2% decline, while the 1 year return sits at 75.3% decline from the current last close of US$11.77. These moves have prompted renewed attention on the business, as...

Sabine Royalty Trust (SBR) is in focus after reporting lower royalty and distributable income for 2025, linked to weaker oil prices and production, partly offset by stronger natural gas pricing. See our latest analysis for Sabine Royalty Trust. At a share price of $72.94, Sabine Royalty Trust has recently seen a 7 day share price return of 4.36%. The 90 day share price return shows a decline of 5.76%, which contrasts with a 1 year total shareholder return of 19.65% and a very large 5 year...

If you are wondering whether Barrick Mining is priced attractively today, you are not alone. This article focuses squarely on what the current share price might mean for value‑focused investors. The stock last closed at US$50.76, with returns of 5.8% over 7 days, a 4.2% decline over 30 days, 15.2% year to date, 192.8% over 1 year and 229.7% over 3 years, which can affect how the market currently thinks about its potential and its risks. Recent news around Barrick Mining has highlighted...

Centuri Holdings (NYSE:CTRI) reported record revenue and profitability for 2025. The company secured a 59% increase in backlog to $5.9b, supporting 2026 revenue visibility. Centuri announced expansion into new states and maintained a 100% Master Service Agreement renewal rate. Management is adjusting fleet funding and working to reduce seasonality in its gas business. Centuri Holdings enters 2026 with fresh momentum, backed by record 2025 financial results and a growing project book. The...

If you are wondering whether WEX at around US$149 per share is offering fair value or a potential bargain, you are not alone in questioning what the current price really reflects. Over shorter periods the stock has been under pressure, with a 5.2% decline over the past week, a 3.5% decline over 30 days, a 5.0% decline over 1 year and a 30.3% decline over 5 years, while the year-to-date return sits at 0.5%. These moves have come as investors continue to reassess payment and fintech related...

American Water Works Company (NYSE:AWK) and its subsidiaries have announced multi state infrastructure investment programs exceeding US$1b to upgrade water and wastewater systems. The initiatives focus on modernizing aging infrastructure, improving system reliability, and reducing service disruptions across several regions. The American Water Charitable Foundation has also launched its 2026 grant program to support water, conservation, and environmental education projects in local...

Lucid Group (NasdaqGS:LCID) is cutting its global workforce by 12% while pushing ahead with higher vehicle production and deliveries. The company is shifting more resources toward autonomous driving capabilities and a potential robotaxi offering. Lucid is also planning new vehicle launches as part of a broader effort to address ongoing losses and improve operational efficiency. Lucid Group, known for its premium electric vehicles, is trying to balance cost control with growth as the EV...

American Tower (AMT) has been in focus after Q4 2025 revenue and profitability topped estimates, 2026 guidance was issued, a share repurchase was completed, and new data center partnerships were announced. See our latest analysis for American Tower. The latest results and 2026 outlook have come alongside a 1 month share price return of 7.84% and a year to date share price return of 9.52%. The 1 year total shareholder return shows a decline of 3.63%, which contrasts with a 10.85% gain over...

OneStream (OS) just closed out FY 2025 with Q4 revenue of US$163.7 million, Basic EPS of US$0.01, and net income of US$1.0 million, set against trailing 12 month revenue of US$601.9 million and a loss of US$50.3 million. The company has seen quarterly revenue move from US$132.5 million in Q4 FY 2024 to US$163.7 million in Q4 FY 2025, while Basic EPS shifted from a loss of US$0.10 to a slight profit of US$0.01 over the same period. This frames a story where top line growth is occurring...

In the past week, Marqeta reported Q4 2025 results showing sales of US$172.11 million, a net loss of US$1.39 million, record total processing volume above US$100 billion, and new Fortune 500 wins, while also issuing 2026 guidance for mid‑teens net revenue and gross profit growth. At the same time, Marqeta flagged that revised, lower pricing and volume shifts with its largest customer, Block, are expected to create headwinds for 2026 gross profit despite the strong recent operating...

In late February 2026, MercadoLibre reported fourth-quarter 2025 revenue of about US$8.76 billion, up from roughly US$6.06 billion a year earlier, while quarterly net income slipped to about US$559 million from roughly US$639 million as heavier spending compressed margins. For 2025 as a whole, revenue climbed to about US$28.89 billion and net income edged up to roughly US$1.997 billion, as Mercado Pago’s rapid payment and credit expansion and higher logistics and AI investment increasingly...

BridgeBio Pharma (NasdaqGS:BBIO) released positive top line Phase 3 data for Encaleret, BBP-418 and Infigratinib. The company reported strong commercial momentum for its product Attruby, supporting a move toward cash generation. Management framed this combination of clinical and commercial news as a pivotal inflection in the business model. BridgeBio Pharma comes into this update with a current share price of $66.445 and a very large 3 year return, alongside a 90.4% return over the past...